At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CURE Direxion Daily Healthcare Bull 3X Shares
Closed 07-22 16:00:00 EDT
112.13
-1.99
-1.74%
盘后112.16
+0.03+0.03%
19:34 EDT
High115.59Low111.40Vol44.26K
Open115.59D1 Closing114.12Amplitude3.68%
Mkt Cap168.20MTradable Cap168.20MTotal Shares1.50M
T/O4.97MT/O Rate2.95%Tradable Shares1.50M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Ascletis Announces Oral Discussion of Asc36_35 Fdc Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/tirzepatide Combination at the 62nd European Association for the Study of Diabetes (easd) Annual Meeting
THOMSON REUTERS  ·  08:10
Ascletis Announces Oral Discussion of Asc36_35 Fdc Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/tirzepatide Combination at the 62nd European Association for the Study of Diabetes (easd) Annual Meeting
Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors
Dow Jones  ·  04:32
Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors
Eli Lilly Updates Financial Calendar with Quarterly Results Conference Call
Reuters  ·  07-22 22:01
Eli Lilly Updates Financial Calendar with Quarterly Results Conference Call
PRESS Digest-british Business - July 22
Reuters  ·  07-22 10:24
PRESS Digest-british Business - July 22
PRESS Digest-financial Times - July 22
Reuters  ·  07-22 09:53
PRESS Digest-financial Times - July 22
Sector Update: Healthcare
MT Newswires Live  ·  07-22 00:59
Sector Update: Healthcare
Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising
MT Newswires Live  ·  07-21 23:49
Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising
Eli Lilly: Rather than Compete on the Merits of Its Products, Novo is Asking Court to Stop Lilly from Communicating Results of That Trial
THOMSON REUTERS  ·  07-21 22:42
Eli Lilly: Rather than Compete on the Merits of Its Products, Novo is Asking Court to Stop Lilly from Communicating Results of That Trial
Eli Lilly on Novo Nordisk Lawsuit- "we Stand Firmly Behind Our Advertising"
THOMSON REUTERS  ·  07-21 22:42
Eli Lilly on Novo Nordisk Lawsuit- "we Stand Firmly Behind Our Advertising"
Eli Lilly: We Will Continue to Focus on the Science and Defend Against Novo Nordisk Lawsuit Vigorously
THOMSON REUTERS  ·  07-21 22:42
Eli Lilly: We Will Continue to Focus on the Science and Defend Against Novo Nordisk Lawsuit Vigorously
U.S. Stocks on the Move-utz Brands, Tutor Perini, Tripadvisor
Reuters  ·  07-21 21:27
U.S. Stocks on the Move-utz Brands, Tutor Perini, Tripadvisor
Novo Nordisk Says Mismatched Diabetes Drug Ads Triggered Lawsuit Vs. Lilly
Dow Jones  ·  07-21 20:23
Novo Nordisk Says Mismatched Diabetes Drug Ads Triggered Lawsuit Vs. Lilly
Novo Sues Lilly, Claiming Misleading Ads in Weight-loss Drug Battle
Reuters  ·  07-21 20:00
Novo Sues Lilly, Claiming Misleading Ads in Weight-loss Drug Battle
Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly
TIPRANKS  ·  07-21 19:51
Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly
Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising
MT Newswires Live  ·  07-21 19:48
Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising
Novo Nordisk Sues Eli Lilly Over Allegedly Misleading GLP-1 Advertising
MT Newswires Live  ·  07-21 19:46
Novo Nordisk Sues Eli Lilly Over Allegedly Misleading GLP-1 Advertising
Novo Nordisk Sues Eli Lilly in U.S. Federal Court, Alleging Claim Under the Lanham Act, Court Records Show
THOMSON REUTERS  ·  07-21 19:32
Novo Nordisk Sues Eli Lilly in U.S. Federal Court, Alleging Claim Under the Lanham Act, Court Records Show
South Africa Regulator Reviews 12 Generic Semaglutide Applications
Reuters  ·  07-21 19:01
South Africa Regulator Reviews 12 Generic Semaglutide Applications
Eli Lilly & Co. Stock Underperforms Monday When Compared to Competitors
Dow Jones  ·  07-21 04:31
Eli Lilly & Co. Stock Underperforms Monday When Compared to Competitors
Eli Lilly May Raise Stake in Scribe Therapeutics to 10.9% Stake Through IPO
MT Newswires Live  ·  07-20 21:08
Eli Lilly May Raise Stake in Scribe Therapeutics to 10.9% Stake Through IPO

Introduction

Company Name.
Direxion Daily Healthcare Bull 3X Shares
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
Issue price:
--